Domestic Surgical Robot Clinical Study
Safety and Feasible Study of Domestic Surgical Robot That Had Been Authorized to Enter the Clinical Trial Stage
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410013
- The Third XIANGYA Hospital of Central South University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of gastric tumor, colorectal tumor, acute cholecystitis and ileocecal tumor respectively
- 18years<age<65years
- male or female
Exclusion Criteria:
- patients with a history of open abdominal surgery
- unstable psychiatric illness
- an inability or reluctance to cooperate during long-term follow-up
- alcohol or drug addiction
- or relatively high surgical risks, such as abnormal coagulation function or bad heart, lung, liver and kidney function, were excluded from this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Micro Hand S robotic group
Micro Hand S robotic surgery group
|
20-70 patients undergo Micro Hand S robotic surgeries
|
|
Other: laparoscopic surgery
laparoscopic surgery group
|
20-70 patients undergo laparoscopic surgeries
|
|
Other: da Vinci robotic group
da Vinci robotic robotic group
|
20-70 patients undergo da Vinci robotic surgeries
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative outcomes
Time Frame: up to 1 week after operation
|
surgical procedure/operative time/console time/blood loss/conversion
|
up to 1 week after operation
|
|
postoperative outcomes
Time Frame: up to 1 month after operation
|
Time to first flatus/intake/hospital stay
|
up to 1 month after operation
|
|
pathological outcomes
Time Frame: up to 1 month after operation
|
resection margin/harvested lymph node/mesorectal grade
|
up to 1 month after operation
|
|
complication
Time Frame: within 30 days after surgery
|
type of complication/grade of complication
|
within 30 days after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
functional outcomes
Time Frame: at least12 months after operation
|
wexner/ipss/iief score
|
at least12 months after operation
|
|
recurrence
Time Frame: at least 12 months after operation
|
local recurrence and metastasis
|
at least 12 months after operation
|
|
survival
Time Frame: at least 12 months yesra after operation
|
disease free survival/overall survival
|
at least 12 months yesra after operation
|
|
change of blood and biochemiacl
Time Frame: within 1 month after operation
|
wbc/hgb/albumin/cea
|
within 1 month after operation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: shaihong zhu, MD, The Third XIANGYA Hospital of Central South University
Publications and helpful links
General Publications
- Lei Y, Jiang J, Zhu S, Yi B, Li J. Comparison of the short-term efficacy of two types of robotic total mesorectal excision for rectal cancer. Tech Coloproctol. 2022 Jan;26(1):19-28. doi: 10.1007/s10151-021-02546-0. Epub 2021 Nov 30.
- Zeng Y, Wang G, Li Z, Lin H, Zhu S, Yi B. The Micro Hand S vs. da Vinci Surgical Robot-Assisted Surgery on Total Mesorectal Excision: Short-Term Outcomes Using Propensity Score Matching Analysis. Front Surg. 2021 May 11;8:656270. doi: 10.3389/fsurg.2021.656270. eCollection 2021.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Infections
- Gastrointestinal Diseases
- Stomach Diseases
- Gastroenteritis
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Peptic Ulcer
- Duodenal Diseases
- Gallbladder Diseases
- Biliary Tract Diseases
- Cecal Diseases
- Intraabdominal Infections
- Calculi
- Appendicitis
- Stomach Ulcer
- Gallstones
- Cholelithiasis
- Cholecystolithiasis
Other Study ID Numbers
Other Study ID Numbers
- XY3-DSRCS1507A01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.